Pulse nav.journalClub 활발한 토론 트렌드 탐색 질문 연구자

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

개인정보 처리방침

홈 탐색 nav.journalClub 트렌드

⌘+K

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection | Synapse

October 14, 2023Open Access

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov Identifier: NCT05094154.

Read Full Paperexternally

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Qian et al. (Sat,) studied this question.

synapsesocial.com/papers/69daa3a28988aeabbe687120 https://doi.org/https://doi.org/10.1001/jama.2023.20583

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam2017 · 61 citations
2Dosing Cefepime for Renal Function Does Not Completely Prevent Neurotoxicity in a Patient With Kidney Transplant2015 · 13 citations
3Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem2019 · 73 citations
4Statistical methods to compare functional outcomes in randomized controlled trials with high mortality2018 · 88 citations
5Notice2012 · 4,348 citations